Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Catecholamines Stories

Brain's Visual Cortex Activates For Reward Even When Stimulus Is Removed
2013-03-22 12:15:13

Alan McStravick for redOrbit.com - Your Universe Online An international collaborative study, conducted by researchers at both KU Leuven and the Harvard Medical School, has attempted to recreate Ivan Pavlov´s famous experiment, but with a twist. Pavlov, you may know, was famous for conducting a study where a stimulus was introduced and the reward for that stimulus was slowly removed, with the aim of observing whether or not a physiological response would continue to be registered...

2013-03-14 20:21:45

SAN DIEGO, March 14, 2013 /PRNewswire-USNewswire/ -- Three studies released today present possible positive news for people with Parkinson's disease. The studies, which will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, March 16 to 23, 2013, report on treatments for blood pressure problems, the wearing-off that can occur when people have taken the main drug for Parkinson's for a long time, and for people early in the disease whose symptoms are not...

2013-03-04 04:21:32

NESS ZIONA, Israel, March 4, 2013 /PRNewswire/ -- NeuroDerm [http://www.neuroderm.com ], Ltd. announced today the results of a Phase I safety and pharmacokinetic trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease. ND0612 is a proprietary levodopa/carbidopa liquid formula administered continuously sub-cutaneously through a patch pump. It is designed to provide steady levodopa blood levels for the reduction of motor complications in Parkinson's...

2013-02-07 08:28:06

KALAMAZOO, Mich., Feb. 7, 2013 /PRNewswire/ -- Metabolic Solutions Development Company, LLC (MSDC) announced today that it has received an award from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to conduct preclinical research on a first-in-class mTOT Modulator, MSDC-0160, as a potential treatment for levodopa induced dyskinesia (LID). The study will be undertaken in collaboration with Patrik Brundin, MD, PhD, of Van Andel Institute (VAI). The aim of the study, titled...

2013-01-25 12:25:43

NEW BRUNSWICK, N.J., Jan. 25, 2013 /PRNewswire-USNewswire/ -- Parkinson's disease affects one million people in the United States and seven million worldwide. While L-Dopa is effective in treating the disease symptoms, the vast majority of patients taking it chronically eventually develop L-Dopa Induced Dyskinesia (LID), abnormal involuntary movements that can be disabling. A new company, MentiNova, Inc., is exploring an oral medication that could reduce these uncontrollable, often chaotic...

2013-01-21 10:20:27

With a new insight into a model of Parkinson´s disease, researchers from the University of Pennsylvania School of Veterinary Medicine have identified a novel target for mitigating some of the disease´s toll on the brain. Narayan G. Avadhani, Harriet Ellison Woodward Professor of Biochemistry and chair of the Department of Animal Biology at Penn Vet, was the senior author on the research. Other department members contributing to the work included Prachi Bajpai, Michelle C. Sangar,...

2013-01-16 23:00:13

Dr. J Marshall Dent has released an article explaining that weight loss occurs in the brain. The balances of many factors play into successful weight loss and maintenance. Columbia, SC (PRWEB) January 16, 2013 Dr. J. Marshall Dent insists that, "people have been taught for years that controlling weight begins and ends with the stomach." The misconception about dieting is it´s all about creating a better ratio of “calories in versus calories out.” The truth is that weight...

Dopamine Therapy Instilling Improved Mobility, Creativeness In Parkinson’s Patients
2013-01-14 11:44:18

Lawrence LeBlond for redOrbit.com - Your Universe Online Health experts around the world are talking about a remarkable phenomenon seen in Parkinson´s patients that was first noticed by researchers at Tel Aviv University´s Sackler Faculty of Medicine over the holidays. Professor Rivka Inzelberg said patients she treated at Sheba Medical Center clinic had skipped bringing the usual presents of chocolate, flowers and knick-knacks in over the holiday season and had instead...

2013-01-08 23:17:36

Penn study suggests dopamine treatments may play role in increasing impulsivity While approximately one in five Parkinson's disease patients experience impulse control disorder symptoms, the disease itself does not increase the risk of gambling, shopping, or other impulsivity symptoms, according to research from the Perelman School of Medicine at the University of Pennsylvania. A new study is the first to show in a large sample that people with untreated Parkinson's were no more likely to...

2012-12-24 15:17:26

Scientists at Karolinska Institutet in Sweden have identified two molecules that play an important role in the survival and production of nerve cells in the brain, including nerve cells that produce dopamine. The discovery, which is published in the journal Nature Chemical Biology, may be significant in the long term for the treatment of several diseases, such as Parkinson's disease. The same scientists have previously shown that receptors known as "liver X receptors" or LXR, are necessary...